Location History:
- Piscataway, NJ (US) (1991)
- East Brunswick, NJ (US) (1997)
Company Filing History:
Years Active: 1991-1997
Title: Metin Akay: Innovator in Noninvasive Cardiac Diagnostics
Introduction
Metin Akay is a prominent inventor based in Piscataway, NJ (US), known for his significant contributions to the field of noninvasive cardiac diagnostics. With a total of two patents to his name, Akay has developed innovative systems that enhance the detection of coronary artery disease.
Latest Patents
Akay's latest patents include a "System and method for noninvasive detection of arterial stenosis" and a "Noninvasive diagnostic system for coronary artery disease." The first patent focuses on utilizing a vasodilator drug to improve the signal-to-noise ratio of acoustic signals representing diastolic heart sounds. This system employs a wavelet transform to create a feature vector that incorporates various clinical parameters, which are then analyzed by neural networks to diagnose coronary stenosis. The second patent outlines a method for analyzing diastolic heart sounds to identify auditory components linked to turbulent blood flow in partially occluded arteries. This system incorporates advanced signal processing techniques and a piezoelectric accelerometer to enhance sensitivity in detecting coronary artery disease.
Career Highlights
Metin Akay is affiliated with Rutgers, the State University of New Jersey, where he continues to advance research in cardiac diagnostics. His work has been instrumental in developing noninvasive methods that reduce the need for more invasive procedures, thereby improving patient care.
Collaborations
Throughout his career, Akay has collaborated with notable colleagues, including Walter Welkowitz and John B Kostis, contributing to the advancement of medical technology and research.
Conclusion
Metin Akay's innovative work in noninvasive cardiac diagnostics exemplifies the impact of technology on healthcare. His patents reflect a commitment to improving diagnostic methods, ultimately benefiting patients and the medical community.